AB Science présentera les résultats de son étude de phase 3 dans l’asthme sévère au Congrès Annuel International de European Respiratory Society

NEXT STORY
SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19
PREV STORY
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ABT ASSOCIATES NAMES ROSLYN M. BROCK CHIEF GLOBAL EQUITY OFFICER

author_avatar
NASDAQ Market News

Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya® over Copaxone® in patients with relapsing remitting multiple sclerosis

Topline findings from ASSESS show adult relapsing remitting multiple sclerosis (RRMS) patients taking Gilenya ...

author_avatar
NASDAQ Market News

Les neuf premiers mois de l’exercice marqués par une croissance de 1% à taux de change constants et par l’impact significatif de la pandémie de COVID-19

author_avatar
NASDAQ Market News